Mariam Rashidzada, PA-C

Mariam Rashidzada practices at NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital.

Mariam Rashidzada's NPI, 1457757395, was assigned on November 4, 2014. Mariam Rashidzada holds New York license 018200.

Mariam Rashidzada's primary practice is NewYork-Presbyterian Queens, at 56-45 Main Street, Flushing, NY 11355 in Queens County. The practice phone is (718) 670-2000.

Mariam Rashidzada's primary practice is NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital. The medical group on file is NewYork-Presbyterian Medical Group Queens. Dmand AI also links Mariam Rashidzada to 6 more group practices and clinics, 5 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mariam Rashidzada practices, 8 sites in all. Vendor and product names are available with a free account.

Surgical is Mariam Rashidzada's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Mariam Rashidzada is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Mariam Rashidzada is licensed in New York.

CMS data shows 95 Medicare services from Mariam Rashidzada across 2 procedure codes in 2024, for 83 Medicare patients. Medicare paid $4,349 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 83 Medicare patients who saw Mariam Rashidzada in 2024. The largest group is 75 to 84, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mariam Rashidzada's median patient age at 69, with 43% women.

In 2024, Mariam Rashidzada wrote 45 Medicare Part D claims for 27 patients. 100% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Mariam Rashidzada for performance year 2024, reported through an alternative payment model (APM). Mariam Rashidzada accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Mariam Rashidzada from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $131.